{"id":31521,"date":"2023-03-27T21:47:06","date_gmt":"2023-03-27T19:47:06","guid":{"rendered":"https:\/\/www.transgene.com\/?p=31521"},"modified":"2025-07-23T17:15:29","modified_gmt":"2025-07-23T15:15:29","slug":"pedro-romero","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/pedro-romero\/","title":{"rendered":"Pedro Romero, MD"},"content":{"rendered":"\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-28055 size-medium aligncenter\" src=\"..\/..\/wp-content\/uploads\/Romero-1.jpg\" alt=\"\" width=\"300\" height=\"300\" \/><\/p>\n<p><strong>Pedro Romero<\/strong>, MD, est professeur \u00e0 la facult\u00e9 de biologie et de m\u00e9decine de l\u2019universit\u00e9 de Lausanne, o\u00f9 il travaille depuis 2003. Il se consacre \u00e0 l\u2019immunologie des tumeurs et \u00e0 l\u2019immunoth\u00e9rapie contre le cancer, en particulier \u00e0 la biologie et \u00e0 la dynamique des r\u00e9ponses des lymphocytes T\u00a0CD8 cytolytiques (CTL). Il est \u00e9galement r\u00e9dacteur en chef du <em>Journal for ImmunoTherapy of Cancer<\/em>.<\/p>\n<p>Auparavant, Pedro a effectu\u00e9 des recherches au d\u00e9partement de parasitologie m\u00e9dicale et mol\u00e9culaire de l\u2019\u00e9cole de m\u00e9decine de l\u2019universit\u00e9 de New York avant de rejoindre l\u2019Institut Ludwig de Recherche contre le Cancer (ILRC), \u00e0 Epalinges, en Suisse, en 1989. En 2001, il est devenu Directeur de la division d\u2019oncoimmunologie clinique au ILRC \u00e0 Lausanne.<\/p>\n<p>Pedro est titulaire de plusieurs brevets et a cosign\u00e9 plus de 320 articles de recherche d\u00e9crivant ses travaux scientifiques dans le domaine de l\u2019immunoth\u00e9rapie \u00e0 base de peptides et des r\u00e9ponses des cellules T.<\/p>\n<p>Pedro a obtenu son doctorat en m\u00e9decine \u00e0 l\u2019\u00e9cole de m\u00e9decine de l\u2019universit\u00e9 nationale de Colombie \u00e0 Bogota.<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pedro Romero, MD, est professeur \u00e0 la facult\u00e9 de biologie et de m\u00e9decine de l\u2019universit\u00e9 de Lausanne, o\u00f9 il travaille depuis 2003. Il se consacre \u00e0 l\u2019immunologie des tumeurs et \u00e0 l\u2019immunoth\u00e9rapie contre le cancer, en particulier \u00e0 la biologie et \u00e0 la dynamique des r\u00e9ponses des lymphocytes T\u00a0CD8 cytolytiques (CTL). Il est \u00e9galement r\u00e9dacteur&hellip; <a class=\"more-link\" href=\"https:\/\/www.transgene.com\/fr\/pedro-romero\/\">Poursuivre la lecture <span class=\"screen-reader-text\">Pedro Romero, MD<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[111],"tags":[],"class_list":["post-31521","post","type-post","status-publish","format-standard","hentry","category-outils-profils","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"Pedro Romero, MD, est professeur \u00e0 la facult\u00e9 de biologie et de m\u00e9decine de l\u2019universit\u00e9 de Lausanne, o\u00f9 il travaille depuis 2003. Il se consacre \u00e0 l\u2019immunologie des tumeurs et \u00e0 l\u2019immunoth\u00e9rapie contre le cancer, en particulier \u00e0 la biologie et \u00e0 la dynamique des r\u00e9ponses des lymphocytes T\u00a0CD8 cytolytiques (CTL). Il est \u00e9galement r\u00e9dacteur&hellip;\u2026","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=31521"}],"version-history":[{"count":0,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31521\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=31521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=31521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=31521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}